Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luxin Sun

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
RSC Chemical Biology|October 25, 2024
Discovery and design of molecular glue enhancers of CDK12-DDB1 interactions for targeted degradation of cyclin KPompom Ghosh, Maximilian Schmitz, Thiyagamurthy Pandurangan, et al.
Journal of Medicinal Chemistry|January 26, 2023
Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) Inhibitors as Male Contraceptives That Reduce Sperm Counts in MiceErik B Faber, Nan Wang, Kristen John, et al.
Nature Communications|June 3, 2023
Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin bindingErik B Faber, Luxin Sun, Jian Tang, et al.
Journal of Medicinal Chemistry|January 14, 2026
Structure-Activity and Structure-Degradation Relationship Studies of 2-Amino-6-(benzimidazol-2-ylmethyl)-N9-heteroarylpurines as Potent and Selective CDK12/13 Inhibitors and Cyclin K DegradersThiyagamurthy Pandurangan, Solomon Tadesse Zeleke, Anna Iermolaieva, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
RSC Chemical Biology|October 25, 2024
Discovery and design of molecular glue enhancers of CDK12-DDB1 interactions for targeted degradation of cyclin KPompom Ghosh, Maximilian Schmitz, Thiyagamurthy Pandurangan, et al.
Journal of Medicinal Chemistry|January 26, 2023
Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) Inhibitors as Male Contraceptives That Reduce Sperm Counts in MiceErik B Faber, Nan Wang, Kristen John, et al.
Nature Communications|June 3, 2023
Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin bindingErik B Faber, Luxin Sun, Jian Tang, et al.
Journal of Medicinal Chemistry|January 14, 2026
Structure-Activity and Structure-Degradation Relationship Studies of 2-Amino-6-(benzimidazol-2-ylmethyl)-N9-heteroarylpurines as Potent and Selective CDK12/13 Inhibitors and Cyclin K DegradersThiyagamurthy Pandurangan, Solomon Tadesse Zeleke, Anna Iermolaieva, et al.
Pageof 2